XML 22 R38.htm IDEA: XBRL DOCUMENT
v2.4.0.8

COMMITMENTS AND CONTINGENCIES (Details) (Daiichi Sankyo, USD $) In Millions, unless otherwise specified | 9 Months Ended
--- | ---
Sep. 30, 2013
Daiichi Sankyo |
Licensing Agreements |
Future milestone payments payable | $ 10.0
Period for which royalties will be paid following the first commercial sale of licensed products in the country | 10 years
Notice period for termination of license by the entity for technical, scientific, efficacy, safety, or commercial reasons | 9 months
Notice period for termination of license after launch of a sapacitabine-based product by the entity, or by either party for material default | 12 months

X
- Definition Represents the notice period for the termination of license after a launch of a sapacitabine-based product, or by either party for material default. + References No definition available. + Details
Name: | cycc_LicenseAgreementNoticePeriodForTerminationOfAgreementAfterLaunchOfSapacitabineBasedProductOrInCaseOfMaterialDefault
Namespace Prefix: | cycc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period for which royalties will be paid following the first commercial sale of licensed products in the country. + References No definition available. + Details
Name: | cycc_LicenseAgreementPeriodForRoyaltiesPaymentAfterFirstCommercialSaleOfLicensedProductsInCountry
Namespace Prefix: | cycc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The potential future milestone payments required to be made under certain contractual agreements. + References No definition available. + Details
Name: | cycc_LicenseAgreementPotentialFutureMilestonePayments
Namespace Prefix: | cycc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents the notice period for the termination of license by the reporting entity for technical, scientific, efficacy, safety, or commercial reasons. + References No definition available. + Details
Name: | cycc_LicensingAgreementNoticePeriodForTerminationOfAgreementDueToTechnicalScientificEfficacySafetyOrCommercialReason
Namespace Prefix: | cycc_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration